Compare RDY & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | GMED |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.8B |
| IPO Year | 2001 | 2012 |
| Metric | RDY | GMED |
|---|---|---|
| Price | $14.39 | $80.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $16.90 | ★ $100.42 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $7.72 | $11.13 |
| Revenue Next Year | $3.50 | $6.28 |
| P/E Ratio | ★ $18.67 | $84.39 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $12.19 | $51.79 |
| 52 Week High | $15.67 | $101.40 |
| Indicator | RDY | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 47.58 |
| Support Level | $13.80 | $75.53 |
| Resistance Level | $14.71 | $86.18 |
| Average True Range (ATR) | 0.34 | 3.09 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 47.88 | 42.29 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.